# Lidocaine and Tetracaine Cream to Treat Postherpetic Neuralgia (PHN)

> **NCT00609323** · PHASE2 · COMPLETED · sponsor: **ZARS Pharma Inc.** · enrollment: 23 (actual)

## Conditions studied

- Postherpetic Neuralgia

## Interventions

- **DRUG:** lidocaine and tetracaine cream 7%/7%
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00609323
- **Lead sponsor:** ZARS Pharma Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2008-07
- **Final completion:** 2008-09
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2012-03-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00609323

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00609323, "Lidocaine and Tetracaine Cream to Treat Postherpetic Neuralgia (PHN)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00609323. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*